Ravi Paluri to Neoplasms
This is a "connection" page, showing publications Ravi Paluri has written about Neoplasms.
Connection Strength
1.099
-
Paluri RK, Li P, Anderson A, Nandagopal L, McArdle T, Young M, Robert F, Naik G, Saleh M. First-In-Human Phase 1 Clinical Trials - A Single-Center Experience In The Era Of Modern Oncotherapeutics. Sci Rep. 2020 05 13; 10(1):7935.
Score: 0.440
-
Paluri R, Madan A, Li P, Jones B, Saleh M, Jerome M, Miley D, Keef J, Robert F. Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2019 03; 83(3):551-559.
Score: 0.400
-
Giri S, Mir N, Al-Obaidi M, Clark D, Kenzik KM, McDonald A, Young-Smith C, Paluri R, Nandagopal L, Gbolahan O, Nyrop KA, Muss HB, Pergolotti M, Bhatia S, Williams GR. Use of Single-Item Self-Rated Health Measure to Identify Frailty and Geriatric Assessment-Identified Impairments Among Older Adults with Cancer. Oncologist. 2022 Feb 03; 27(1):e45-e52.
Score: 0.124
-
Giri S, Al-Obaidi M, Weaver A, Kenzik KM, McDonald A, Clark D, Young-Smith C, Paluri R, Nandagopal L, Gbolahan O, Pergolotti M, Bhatia S, Williams GR. Association Between Chronologic Age and Geriatric Assessment-Identified Impairments: Findings From the CARE Registry. J Natl Compr Canc Netw. 2021 Jun 11; 19(8):922-927.
Score: 0.119
-
Sonpavde G, Je Y, Schutz F, Galsky MD, Paluri R, Rosenberg JE, Bellmunt J, Choueiri TK. Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis of randomized clinical trials. Crit Rev Oncol Hematol. 2013 Jul; 87(1):80-9.
Score: 0.017